1. Selective macrophage ascorbate deficiency suppresses early atherosclerosis. Babaev VR, Whitesell RR, Li L, Linton MF, Fazio S, May JM (2011) Free Radic Biol Med 50(1): 27-36
    › Citation · 20974251 (PubMed) · PMC3014415 (PubMed Central)
  2. Role of TAPP1 and TAPP2 adaptor binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis. Wullschleger S, Wasserman DH, Gray A, Sakamoto K, Alessi DR (2011) Biochem J 434(2): 265-74
    › Citation · 21204784 (PubMed) · PMC4461655 (PubMed Central)
  3. Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA (2011) Diabetes 60(3): 827-37
    › Citation · 21266327 (PubMed) · PMC3046843 (PubMed Central)
  4. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Yamamoto S, Zuo Y, Ma J, Yancey PG, Hunley TE, Motojima M, Fogo AB, Linton MF, Fazio S, Ichikawa I, Kon V (2011) Nephrol Dial Transplant 26(8): 2491-7
    › Citation · 21245127 (PubMed) · PMC3203394 (PubMed Central)
  5. Obesity impairs skeletal muscle AMPK signaling during exercise: role of AMPKα2 in the regulation of exercise capacity in vivo. Lee-Young RS, Ayala JE, Fueger PT, Mayes WH, Kang L, Wasserman DH (2011) Int J Obes (Lond) 35(7): 982-9
    › Citation · 21079619 (PubMed) · PMC3049903 (PubMed Central)
  6. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF, Herrera PL, Peterson TE, Meda P, Powers AC (2011) Proc Natl Acad Sci U S A 108(51): 20719-24
    › Citation · 22143775 (PubMed) · PMC3251115 (PubMed Central)
  7. Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Chen S, Wasserman DH, MacKintosh C, Sakamoto K (2011) Cell Metab 13(1): 68-79
    › Citation · 21195350 (PubMed) · PMC3081066 (PubMed Central)
  8. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V (2011) Arterioscler Thromb Vasc Biol 31(12): 2856-64
    › Citation · 21979434 (PubMed) · PMC3227118 (PubMed Central)
  9. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes. Babaev VR, Runner RP, Fan D, Ding L, Zhang Y, Tao H, Erbay E, Görgün CZ, Fazio S, Hotamisligil GS, Linton MF (2011) Arterioscler Thromb Vasc Biol 31(6): 1283-90
    › Citation · 21474828 (PubMed) · PMC3135083 (PubMed Central)
  10. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent. Yancey PG, Ding Y, Fan D, Blakemore JL, Zhang Y, Ding L, Zhang J, Linton MF, Fazio S (2011) Circulation 124(4): 454-64
    › Citation · 21730304 (PubMed) · PMC3144781 (PubMed Central)